460 results on '"Urien, Saïk"'
Search Results
2. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers
3. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
4. Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty
5. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial
6. Population pharmacokinetics of meropenem in critically ill children with different renal functions
7. Forecasting the Patients Flow at Pediatric Emergency Departments
8. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance
9. Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN‐PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births
10. Supplementary Fig S1-S8 from Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
11. Supplementary Table S1-S6 from Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
12. Data from Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
13. Impact of antiretroviral treatment on height evolution of HIV infected children
14. Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery
15. Plasma and intraprostatic concentrations of ertapenem following preoperative single dose administration: a single-centre prospective experience and clinical implications—the ERTAPRO study
16. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy
17. Modeling for critically ill patients: An introduction for beginners
18. Challenges regarding analysis of unbound fraction of highly bound protein antiretroviral drugs in several biological matrices: lack of harmonisation and guidelines
19. Amiodarone/N‐desethylamiodarone population pharmacokinetics in paediatric patients
20. Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
21. General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children.
22. Vancomycin Pharmacokinetic and Pharmacodynamic Models for Critically Ill Patients with Post-Sternotomy Mediastinitis
23. A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
24. Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) and Ductus Arteriosus Closure After Premature Birth
25. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial
26. Prediction of drug clearance in children
27. Intravenous morphine titration in immediate postoperative pain management: Population kinetic–pharmacodynamic and logistic regression analysis
28. Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics
29. Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach
30. Population pharmacokinetics and haemodynamic effects of norepinephrine in hypotensive critically ill children
31. Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
32. Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach
33. Moxifloxacin versus placebo modeling of the QT interval
34. Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients
35. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy
36. Population Pharmacokinetics of Ceftriaxone and Pharmacodynamic Considerations in Haemodialysed Patients
37. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance
38. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial
39. Estimation of piperacillin clearance with different glomerular filtration rate formulas in critically ill children
40. Didanosine population pharmacokinetics in West African HIV-infected children administered once daily tablets in relation to efficacy after one year of treatment (ANRS 12103)
41. Are recommended doses of efavirenz optimal in young children? (ANRS 12103)
42. Evaluation of nevirapine dosing recommendations in HIV-infected children
43. Vitamin D3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol
44. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis
45. In Vitro Binding and Partitioning of Irinotecan (CPT-11) and its Metabolite, SN-38, in Human Blood
46. Reevaluation of Moxifloxacin Pharmacokinetics and Their Direct Effect on the QT Interval
47. Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents
48. Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory – immunonologic conditions
49. Population pharmacokinetics of meropenem in critically ill children with different renal functions
50. Effet de l'inhibition des transporteurs OAT1 et MRP2 sur la clairance de l'adéfovir
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.